Registration is open! You have another 12 days to submit your application.
Registration is open! You have another 12 days to submit your application.
APPLY
GENOSOPHY® is the first spin-off of the National and Kapodistrian University of Athens (NKUA). In GENOSOPHY® we have a strong commitment towards improving human health through the provision of a comprehensive range of predictive, preventive and personalized genomic services. The company has established and operates a technology platform that enables patients and healthy individuals to harmonize their nutritional and lifestyle behaviors with their genetic make-up.
The GENOSOPHY® platform comprises the most comprehensive nutrigenetic test worldwide coupled to an innovative algorithm which has been registered as NKUA trade secret. The algorithm incorporates >750.000 genetic data together with health and lifestyle parameters to derive risk scores for diet-related diseases, such as obesity, type 2 diabetes, CVD, etc., and lifestyle interventions to mitigate these risks. Compared to competitors, GENOSOPHY® offers unprecedented breadth of DNA analysis that enables: (a) superior and more accurate recommendations and, (b) lifelong partnership with the client who could obtain new information derived from his/her genetic data at any stage without the need to perform another DNA test. Compared to conventional dietary and lifestyle plans, GENOSOPHY® has demonstrated superior efficacy for the management of obesity and diabetes and.
The GENOSOPHY® platform received the 2023 NKUA Innovation Award and has already customers in Greece, Cyprus, Albania, Germany and Switzerland.
